A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

Clinical trial NCT07446049 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07446049
Sponsor: Convalife (Shanghai) Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors PTEN Loss or Low Expression

Start date: 2026-05-01
Primary completion: 2028-01-09
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.